|
|
Line 39: |
Line 39: |
| *This study found that the provision of NVPs for 12 weeks was associated with 7-day point prevalence tobacco smoking abstinence among 35% of a sample of PLHIV who smoked tobacco daily. These findings suggest that NVPs represent a potentially feasible and effective short-to-medium term tobacco smoking cessation aid and/or tobacco harm reduction strategy among PLHIV. | | *This study found that the provision of NVPs for 12 weeks was associated with 7-day point prevalence tobacco smoking abstinence among 35% of a sample of PLHIV who smoked tobacco daily. These findings suggest that NVPs represent a potentially feasible and effective short-to-medium term tobacco smoking cessation aid and/or tobacco harm reduction strategy among PLHIV. |
| <br> | | <br> |
|
| |
| ='''Studies Vaping - Combined Intending and Not Intending to Quit Smoking'''=
| |
|
| |
| ===2021: [https://www.ingentaconnect.com/contentone/png/ajhb/2021/00000045/00000003/art00004#expand/collapse Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System]===
| |
| *Rates of switching with JUUL increased over time. Over 50% of respondents reported complete switching away from cigarettes 12 months following purchase. Greater use of and dependence on JUUL predicted switching.
| |
|
| |
|
| ='''Long Term Smoking Abstinence'''= | | ='''Long Term Smoking Abstinence'''= |